Featured
-
-
News Explainer |
Chance of heatwaves in India rising with climate change
Not only are these extreme events increasing in frequency, they are lasting longer and becoming hotter, too.
- Jude Coleman
-
News Feature |
A myopia epidemic is sweeping the globe. Here’s how to stop it
Time spent outdoors is the best defence against rising rates of short-sightedness, but scientists are searching for other ways to reverse the troubling trend.
- Elie Dolgin
-
Outlook |
Advances in highly targeted radiation treatment for cancer have ignited interest in a once obscure field
Therapies that treat while diagnosing — theranostics — can extend length of survival and improve the quality of life for some people with advance-stage cancer.
- Rachel Nuwer
-
Outlook |
Randomized trials of cancer drugs are for yesterday
Pitting new treatments against old, ineffective agents is neither ethical nor economical.
- Elaine Schattner
-
Outlook |
How antibody–drug conjugates aim to take down cancer
Scientists are trying to work out how to balance potency with toxicity and tackle the cost of next-generation therapeutics.
- Benjamin Plackett
-
Outlook |
Turning tumours against themselves
Advances in in situ therapeutic cancer vaccines offer a mode of treatment that could redeem the promise of previous false dawns.
- Liam Drew
-
Outlook |
AI assistance for planning cancer treatment
Armed with the right data, advances in machine learning could help oncologists to home in quickly on the best treatment strategies for their patients.
- Michael Eisenstein
-
Outlook |
Natural killer cells show their cancer-fighting worth
Although natural-killer-cell therapies are safer than T-cell therapies and offer other advantages, they require upgrades to overcome their limited lifespan and susceptibility to immunosuppression.
- Amanda B. Keener
-
Comment |
Heed lessons from past studies involving transgender people: first, do no harm
Decades of neuroscientific work have focused on exploring a biological basis for transgender identity — but researchers must take societal factors into account.
- Mathilde Kennis
- , Robin Staicu
- & Felix Duecker
-
News |
Ozempic keeps wowing: trial data show benefits for kidney disease
Semaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for people with diabetes.
- Rachel Fairbank
-
Article
| Open AccessA whole-slide foundation model for digital pathology from real-world data
Prov-GigaPath, a whole-slide pathology foundation model pretrained on a large dataset containing around 1.3 billion pathology images, attains state-of-the-art performance in cancer classification and pathomics tasks.
- Hanwen Xu
- , Naoto Usuyama
- & Hoifung Poon
-
Correspondence |
Trials that infected people with common colds can inform today’s COVID-19 challenge trials
- Jonathan Ewbank
-
Editorial |
A global pandemic treaty is in sight: don’t scupper it
Millions of people died of COVID-19 because the fundamental principle of equity between nations was ignored during the outbreak. That must not be allowed to happen again.
-
News |
Could bird flu in cows lead to a human outbreak? Slow response worries scientists
The H5N1 virus is a long way from becoming adapted to humans, but limited testing and tracking mean we could miss danger signs.
- Smriti Mallapaty
-
Clinical Briefing |
mRNA therapy is safe for treating the inherited metabolic condition propionic acidaemia
Propionic acidaemia is an inheirited metabolic condition caused by a lack of a liver enzyme, which leads to accumulation of toxic compounds. In a first-in-human trial, a therapeutic messenger RNA drug (mRNA-3927) led to restored enzyme activity, was well tolerated and showed a promising dose-dependent reduction of potentially life-threatening clinical events.
-
Comment |
Neglecting sex and gender in research is a public-health risk
The data are clear: taking sex and gender into account in research and using that knowledge to change health care could benefit billions of people.
- Sue Haupt
- , Cheryl Carcel
- & Robyn Norton
-
Correspondence |
Interpersonal therapy can be an effective tool against the devastating effects of loneliness
- Myrna M. Weissman
- & Jennifer J. Mootz
-
News |
Is the Internet bad for you? Huge study reveals surprise effect on well-being
A survey of more than 2.4 million people finds that being online can have a positive effect on welfare.
- Carissa Wong
-
Outlook |
How ignorance and gender inequality thwart treatment of a widespread illness
Tens of millions of people have female genital schistosomiasis, a neglected tropical disease that few physicians have even heard of. Efforts are under way to move it out of obscurity and empower women and girls to access sexual and reproductive health care.
- Claire Ainsworth
-
News |
Bird flu in US cows: where will it end?
Scientists worry that the H5N1 strain of avian influenza will become endemic in cattle, which would aid its spread in people.
- Sara Reardon
-
News |
US funders to tighten oversight of controversial ‘gain of function’ research
New policy on high-risk biology studies aims to address criticism that previous rules were too vague.
- Max Kozlov
-
News & Views |
Microbubble ultrasound maps hidden signs of heart disease
Cardiovascular disease claims more lives each year than do the two next-deadliest diseases combined. An ultrasound technique that tracks tiny gas-filled bubbles could pave the way towards improved early detection.
- Elisa E. Konofagou
-
Career Feature |
Hunger on campus: why US PhD students are fighting over food
Graduate students are relying on donated and discounted food in the struggle to make ends meet.
- Laurie Udesky
-
Comment |
We need more-nuanced approaches to exploring sex and gender in research
Some scientists are reluctant to investigate questions about sex and gender, particularly given today’s sociopolitical tensions around gender identity. But they should lean in and embrace the complexity.
- Stacey A. Ritz
- & Lorraine Greaves
-
Research Briefing |
Endurance exercise causes a multi-organ full-body molecular reaction
A study of male and female rats has examined the biomolecular changes induced in many of their organs by eight weeks of endurance treadmill training. The findings offer insights into the many benefits to our immune, metabolic and stress-response pathways as we adapt to exercise.
-
News Feature |
Do cutting-edge CAR-T-cell therapies cause cancer? What the data say
Regulators have identified around 30 cases of cancer linked to this blockbuster treatment. But is CAR T to blame? The hunt is on for answers.
- Cassandra Willyard
-
News |
Bird flu virus has been spreading among US cows for months, RNA reveals
Genomic analysis suggests that the outbreak probably began in December or January, but a shortage of data is hampering efforts to pin down the source.
- Smriti Mallapaty
-
News |
Could a rare mutation that causes dwarfism also slow ageing?
People with Laron syndrome have a low risk of heart disease and a number of other age-related disorders, hinting at strategies for new treatments.
- Mariana Lenharo
-
Outlook |
Are robots the solution to the crisis in older-person care?
Social robots that promise companionship and stimulation for older people and those with dementia are attracting investment, but some question their benefits.
- Tammy Worth
-
Arts Review |
Las Borinqueñas remembers the forgotten Puerto Rican women who tested the first pill
Clinical trials of the first oral contraceptive recalled in a bold theatre production.
- Mariana Lenharo
-
News & Views |
Targeting RNA opens therapeutic avenues for Timothy syndrome
A therapeutic strategy that alters gene expression in a rare and severe neurodevelopmental condition has been tested in stem-cell-based models of the disease, and has been shown to correct genetic and cellular defects.
- Silvia Velasco
-
News |
WHO redefines airborne transmission: what does that mean for future pandemics?
The World Health Organization was criticized for being too slow to classify COVID-19 as airborne. Will the new terminology help next time?
- Bianca Nogrady
-
Correspondence |
More work is needed to take on the rural wastewater challenge
- Jinlou Huang
- , Duo Li
- & Xiao Jin Yang
-
News |
Monkeypox virus: dangerous strain gains ability to spread through sex, new data suggest
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak.
- Max Kozlov
-
Editorial |
Any plan to make smoking obsolete is the right step
The United Kingdom is correct to attempt to end the single largest preventable cause of illness and death, as was New Zealand before its government changed its mind.
-
Where I Work |
How ground glass might save crops from drought on a Caribbean island
In Grenada, public-health researcher Lindonne Telesford tests a soil additive made from recycled glass that could help farmers adapt to climate change.
- Kendall Powell
-
News Feature |
What toilets can reveal about COVID, cancer and other health threats
Wastewater testing grew tremendously during the pandemic. But is it ready to tackle the opioid crisis, air pollution and antibiotic resistance?
- Betsy Ladyzhets
-
News |
Smoking bans are coming: what does the evidence say?
Countries are cracking down on tobacco use and vaping — the laws could save thousands of lives and billions of dollars, say scientists.
- Carissa Wong
-
Correspondence |
It’s time to talk about the hidden human cost of the green transition
- Manuel Prieto
- & Nicolás C. Zanetta-Colombo
-
News |
Lethal dust storms blanket Asia every spring — now AI could help predict them
As the annual phenomenon once again strikes East Asia, scientists are hard at work to better predict how they will affect people.
- Xiaoying You
-
News Explainer |
Bird flu outbreak in US cows: why scientists are concerned
A virus that has killed hundreds of millions of birds has now infected cattle in six US states, but the threat to humans is currently low.
- Max Kozlov
- & Smriti Mallapaty
-
Nature Podcast |
Audio long read: Why are so many young people getting cancer? What the data say
Researchers are scrambling to explain why rates of multiple cancers are increasing among adults under the age of 50.
- Heidi Ledford
- & Benjamin Thompson
-
Editorial |
Time to sound the alarm about the hidden epidemic of kidney disease
With rates rising around the world, public-health leaders must prioritize prevention, treatment, funding and data.
-
Correspondence |
Adopt universal standards for study adaptation to boost health, education and social-science research
- Dragos Iliescu
- & Samuel Greiff
-
News Feature |
Long COVID still has no cure — so these patients are turning to research
With key long COVID trials yet to yield results, people with the condition are trying to change how clinical trials are done.
- Rachel Fairbank
-
Book Review |
The great rewiring: is social media really behind an epidemic of teenage mental illness?
The evidence is equivocal on whether screen time is to blame for rising levels of teen depression and anxiety — and rising hysteria could distract us from tackling the real causes.
- Candice L. Odgers
-
Nature Video |
No sweat: Moisture-wicking device keeps wearable-tech dry
Breathable patch could allow for comfortable and multifunctional wearable electronics.
- Dan Fox
-
News & Views |
Anti-ageing antibodies revive the immune system
Depleting an expanding pool of aberrant stem cells in aged mice using antibody therapy has been shown to rebalance blood cell production, diminish age-associated inflammation and strengthen acquired immune responses.
- Yasar Arfat T. Kasu
- & Robert A. J. Signer
-
News |
Abortion-pill challenge provokes doubt from US Supreme Court
Lawsuit could roll back access to mifepristone, a drug widely used to induce abortion in the United States.
- Mariana Lenharo